Shree Ganesh Remedies' record carries seven consecutive unqualified audit opinions, but the FY2023 restatement and a collapse in operating cash flow against rising profit are the two things a reader should understand first. The company restated multiple years of financials under Ind AS 8, and its cash conversion has deteriorated sharply in the latest year.
Key findings
- Company restated multiple years of financials after certifying no errors existed
Critical- The company restated FY2023 financials under Ind AS 8, with net impact on profit before tax of ₹(234.66) lakhs for the year ended March 31, 2023. The FY2022-23 Annual Report had stated "No prior period errors identified", and the FY2021-22 report stated no changes in accounting policies, both before the restatement was disclosed on 1 Jun 2024. The auditor's report dated 1 Jun 2024 included an Emphasis of Matter, a special call-out in the audit report, on the restatement, with opinion not modified. - Operating cash flow collapsed to zero against rising profit, with no dividend for two years
Major- CFO/PAT fell from 1.33x in FY25 to 0.00x in FY26, with CFO of ₹0.00 crore against PAT of ₹17.76 crore. No dividend was proposed for FY ended March 31, 2026, with profit of ₹17.77 crore transferred to Reserve and Surplus Account, and dividend declared and paid was ₹Nil per equity share for both FY2025-26 and FY2024-25. ROCE declined from 24.45% in FY24 to 18.18% in FY25 and 14.24% in FY26. - Reported "debt-free" balance sheet masks ₹25.49 crore of mortgaged PPE and secured working capital facilities
Major- The FY2025-26 Annual Report describes the balance sheet as "lean and close to debt-free" while simultaneously disclosing that Property, Plant and Equipment amounting to ₹25.49 crore is mortgaged against borrowings. Inventories and trade receivables are both given as security to bankers by way of first pari passu charge against fund-based working capital limits. Mortgaged PPE was ₹3.28 crore in FY2023-24, a 677% increase to ₹25.49 crore in FY2025-26. - Revenue recognition flagged as a Key Audit Matter, with receivables growing faster than revenue
Major- The independent auditor identified revenue recognition as a Key Audit Matter in the FY2021-22 consolidated financial statements due to the risk of material misstatement from revenue being recorded in the incorrect period. Receivable days rose from 58.95 days in FY24 to 74.85 days in FY25 and further to 109 days in FY26, while revenue declined from ₹126 crore in FY24 to ₹109 crore in FY25 and ₹109 crore in FY26. - Promoter family controls every executive seat, with zero promoter votes cast on their own appointments
Major- At the EGM held April 6, 2026, the re-appointment of Mr. Parth Chandulal Kothia as Whole-time Director and CFO passed with 99.96% of votes polled in favour, but the promoter and promoter group holding 9,350,529 shares polled 0 votes. At the September 28, 2022 AGM, resolutions for re-appointment of directors each passed with 100% of valid public votes in favour, but 7,184,878 promoter votes polled were considered invalid on each resolution. The FY2023-24 Secretarial Auditor's report stated no changes in board composition, contradicting the Directors' Report which records resignations of two Independent Directors w.e.f. November 10, 2023. - Auditor churn accelerated from 2021 to 2024, three different audit firms in four years
Major- M/s. Bansi S. Mehta & Co. was appointed as statutory auditor for 5 consecutive years from the 28th AGM (2023), but resigned vide letter dated August 14, 2024, creating a casual vacancy. The firm confirmed no material reason other than those provided in its resignation letter. M/s. Rushik J Patel & Co. was the statutory auditor for FY2020-21, and M/s. J. K. Shah & Associates audited the consolidated financial statements for FY2021-22. - Promoter-group entities and directors are recurring counterparties for loans, purchases and remuneration
Minor- An EGM notice dated 13 Mar 2026 seeks member approval for related-party remuneration to Mr. Gunjan Chandulal Kothia (son of MD, brother of WTD/CFO) of up to Rs. 1,08,00,000/- per annum, described as arm's length and ordinary course. In FY2023-24, "Loans from Directors are repayable on demand and interest free". In FY2025-26, Form AOC-2 states no contracts/arrangements with related parties not at arm's length basis (NIL). - Seven years of unqualified opinions with clean CARO responses, but with an audit-trail exception and unaudited overseas subsidiary
Minor- The standalone financial statements received an unqualified opinion for every year from FY2020 through FY2026. The FY2024 standalone audit report contained a Section 143(3)(b) exception stating the audit trail feature was NOT enabled at the database level to log direct data changes, though no tampering was found. The FY2026 consolidated audit report disclosed that one subsidiary located outside India was NOT audited, with its financial statements prepared and certified by management, showing total assets ₹3.62 lakhs and total net loss after tax ₹(1.34) lakhs.
What to watch
- Dividend resumption. Whether the company resumes dividend payments or transfers FY2025-26 profit of ₹17.77 crore to reserves, as disclosed in the FY2025-26 Annual Report.
- Cash flow recovery. Whether CFO recovers from ₹0.00 crore in FY26 toward the FY24-FY25 levels of ₹30.45-30.66 crore, to be reported in the FY2026-27 annual results.
- Auditor tenure. Whether M/s. Chaudhary Shah & Associates LLP completes its five-year term (2024-2029) or resigns early, following the pattern of Bansi S. Mehta & Co. resigning after two years of a five-year term.
- Auditor's SA 720 communication. The FY2026 annual report's "Other information" was not available at the audit report date of May 14, 2026, whether the auditor issues any subsequent communication under SA 720 after reading that information.
- Overseas subsidiary audit. Whether the unaudited overseas subsidiary (total assets ₹3.62 lakhs, net loss ₹1.34 lakhs for FY2026) is audited in the FY2026-27 consolidated audit.
Bottom line: This is an audited record with clean opinions, but the restatement and the cash-flow collapse are the two events that define the current picture. The restatement shows the prior certifications of no errors were wrong, and the latest year's profit carries no operating cash at all. Watch whether cash generation recovers and whether the auditor completes its term.